End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
781,000 KRW | +0.77% | -2.62% | +2.76% |
04-25 | Samsung Bioepis Granted Approval to Market Autoimmune Treatment in Europe | MT |
04-25 | Samsung Biologics Posts Higher Q1 Profit, Sales | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.76% | 40.1B | |
-3.45% | 87.17B | |
-16.98% | 31.38B | |
+57.86% | 25.12B | |
-16.24% | 15.59B | |
-9.12% | 12B | |
-42.56% | 11.8B | |
-17.10% | 11.8B | |
+6.89% | 8.81B | |
-10.53% | 8.24B |
- Stock Market
- Equities
- A207940 Stock
- News Samsung Biologics Co.,Ltd.
- Market Chatter: Samsung Biologics Eyes Inaugural Public Bond Offering